• UCSBengineering twitter avatar
    Three UCSB Engineering Professors Named Fellows of the American Physics Society @APSphysics https://t.co/yku8XgQE3Q https://t.co/anwBXJNpCL
    1 hour 5 min ago
  • UCSBgauchos twitter avatar
    Gauchos Hold On For 68-61 Win at USF https://t.co/h3KlZ93zpT
    14 hours 47 min ago
  • UCSB_GradPost twitter avatar
    USAID Hosts Free Live Facebook Chat ‘Food Security in a Time of Global Climate Change… https://t.co/twPISPDdk6 #UCSB
    18 hours 31 min ago
  • UCSBgauchos twitter avatar
    No. 15 @UCSBMensSoccer flies east to take on Clemson in the Sweet Sixteen, televised on ESPN3. PREVIEW >>> https://t.co/IoE9rPbfi8
    22 hours 22 min ago
  • UCSBengineering twitter avatar
    A day in the life of a #NASA #Engineer -- an inspiration for #UCSB engineers https://t.co/NWnguqk1Tr
    23 hours 50 min ago

UCSB Postdoctoral Researcher Wins Fellowship

Monday, June 9, 2003 - 17:00
Santa Barbara, CA

Tina M. Trnka, a postdoctoral researcher at the University of California, Santa Barbara, has won a fellowship awarded by the Damon Runyon Cancer Research Foundation, among only fourteen awarded nationally.

According to the foundation, "The recipients of this prestigious award are outstanding young scientists conducting theoretical and experimental research that is relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention."

Trnka works in the lab of Galen Stucky, professor of chemistry and materials. She explained that there is a great need for improved chemotherapy treatments to combat cancer. "One strategy, the targeted delivery of drug molecules to specific cancer cells, aims to both enhance the effectiveness of these drugs and alleviate their toxicity to healthy cells. However, this concept has been difficult to implement because of problems with the stability, activity, selectivity, or delivery of many drug carrier combinations."

Trnka's research is an attempt to use state-of-the-art, nano-sized, composite materials for the delivery of drugs to cancer cells. The goal is to load nano-scale hollow spheres with doses of chemotherapy agents. Trnka's research proposal targets cocktails of multiple drugs to ovarian cancer cells.

She will receive $128,500 over a three year period, with some of the money going toward travel to professional meetings and research equipment and supplies.

"It's a real honor and incredible opportunity to have the support of the Damon Runyon foundation," said Trnka.

Some awards are sponsored by specific donors, and Trnka's sponsor is Cheryl Breetwor, founder of ShareData, Inc., which was acquired by E*Trade in 1998. Trnka has already met with Breetwor and with the executive director of the foundation.

After reading this article I feel